Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin ODT for Nocturia in Adult Females
NCT01223937Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2010
- Primary completion
- Nov 2011
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Ferring Pharmaceuticals. Started Nov 2010; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01223937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223937.